Novartis' Alzheimer's Disease Web Site Receives Awards for Content, Interactive Design and Best Pharmaceutical Site

Apr 12, 2001, 01:00 ET from Novartis Pharmaceuticals Corporation

    EAST HANOVER, N.J., April 12 /PRNewswire/ -- Novartis Pharmaceuticals
 Corporation's interactive Alzheimer's disease online resource,
 AlzheimersDisease.com, received awards in three separate categories in the
 First Annual eHealthcare Leadership Awards. AlzheimersDisease.com won silver
 awards in the categories of Best Health/Healthcare Content, Best Interactive
 Site, and Best Internet Site for pharmaceutical companies.
 The awards were presented by eHealthcare Strategy and Trends, an online
 publication that provides news and feature articles on Internet strategies and
 technology for the healthcare industry.
     The first annual eHealthcare Leadership Awards drew nearly 400 entries
 from small and large hospitals, health systems, medical practices, managed
 care organizations, healthcare associations, consumer health portals and
 pharmaceutical companies, among others.  Web sites were judged based on a
 standard of Internet excellence and how they compared with other sites within
 their classification.  Judging was done by forty individuals with a variety of
 expertise in healthcare and information technology.
     "Novartis is extremely pleased to have received these recognitions for
 AlzheimersDisease.com," said Andy Volante, Executive Director and Group Brand
 Leader. "As a company, Novartis is committed to providing valuable resources
 for healthcare professionals, the millions of people with Alzheimer's disease
 and their caregivers through our involvement with educational initiatives such
 as AlzheimersDisease.com.  It is very gratifying to know that our site has
 been recognized as an example of excellence by leaders in the fields of
 healthcare and information technology."
     AlzheimersDisease.com is divided into two primary sections, one for
 caregivers and one for healthcare providers. The caregiver-directed segment of
 the Web site is designed to provide tailored educational resources and support
 to caregivers so that they can more effectively support the loved one in their
 care.  Content in the section, titled "Caregiver's Corner," is provided by
 Mayo Clinic.  It allows Alzheimer's disease caregivers to tap into the
 expertise and resources of Mayo Clinic's Alzheimer's experts.  "Caregiver's
 Corner" is updated monthly to address a wide array of changing caregiver
 issues.
     "'Caregiver's Corner' is provided as part of Mayo Clinic's commitment to
 serve as a reliable and objective source of health information for the
 public," said Dr. Brooks Edwards, medical editor, MayoClinic.com. "The monthly
 articles are specifically designed to address the many challenges that
 caregivers of Alzheimer's patients face on a daily basis."
     The professional component of the site is designed to meet the varied
 needs of healthcare professionals by providing timely, practical information
 directly relevant to the treatment of Alzheimer's disease in clinical
 practice, as well as important issues related to caregiving. It includes
 information about the pathophysiology of Alzheimer's disease, diagnosis,
 caregiver issues, and provides a calendar/overview of upcoming medical
 meetings offering symposia related to the treatment of the disease.
     Alzheimer's disease is a neurodegenerative disease involving deterioration
 of the brain.  Memory loss, behavioral problems and the inability to perform
 daily activities are hallmarks of this fatal disease.  Alzheimer's disease,
 the fourth leading cause of death behind cardiovascular disease, cancer and
 stroke, affects up to four million adults in the United States, and ten
 million worldwide.  It has an annual U.S. price tag of approximately $100
 billion in direct (healthcare and related) and indirect (income) costs.
 
     Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation
 is an affiliate of the Novartis Group (NYSE:   NVS), a world leader in
 healthcare with core businesses in pharmaceuticals, consumer health, generics,
 eye-care, and animal health. In 2000, the Group's ongoing businesses achieved
 sales of CHF 29.1 billion (USD 17.2 billion) and invested approximately CHF
 4.0 billion (USD 2.4 billion) in R&D. Headquartered in Basel, Switzerland,
 Novartis employs about 67,600 people and operates in over 140 countries around
 the world. For further information please consult http://www.novartis.com.
 
     Contact:
     Gina Moran
     Novartis Pharmaceuticals Corporation
     PH: (973) 781-5567
     FX: (973) 781-7828
 
     Rod Smith
     Feinstein Kean Healthcare
     PH: (617) 761-6723
     FX: (617) 577-8985
     Rsmith@fkhealth.com
 
 

SOURCE Novartis Pharmaceuticals Corporation
    EAST HANOVER, N.J., April 12 /PRNewswire/ -- Novartis Pharmaceuticals
 Corporation's interactive Alzheimer's disease online resource,
 AlzheimersDisease.com, received awards in three separate categories in the
 First Annual eHealthcare Leadership Awards. AlzheimersDisease.com won silver
 awards in the categories of Best Health/Healthcare Content, Best Interactive
 Site, and Best Internet Site for pharmaceutical companies.
 The awards were presented by eHealthcare Strategy and Trends, an online
 publication that provides news and feature articles on Internet strategies and
 technology for the healthcare industry.
     The first annual eHealthcare Leadership Awards drew nearly 400 entries
 from small and large hospitals, health systems, medical practices, managed
 care organizations, healthcare associations, consumer health portals and
 pharmaceutical companies, among others.  Web sites were judged based on a
 standard of Internet excellence and how they compared with other sites within
 their classification.  Judging was done by forty individuals with a variety of
 expertise in healthcare and information technology.
     "Novartis is extremely pleased to have received these recognitions for
 AlzheimersDisease.com," said Andy Volante, Executive Director and Group Brand
 Leader. "As a company, Novartis is committed to providing valuable resources
 for healthcare professionals, the millions of people with Alzheimer's disease
 and their caregivers through our involvement with educational initiatives such
 as AlzheimersDisease.com.  It is very gratifying to know that our site has
 been recognized as an example of excellence by leaders in the fields of
 healthcare and information technology."
     AlzheimersDisease.com is divided into two primary sections, one for
 caregivers and one for healthcare providers. The caregiver-directed segment of
 the Web site is designed to provide tailored educational resources and support
 to caregivers so that they can more effectively support the loved one in their
 care.  Content in the section, titled "Caregiver's Corner," is provided by
 Mayo Clinic.  It allows Alzheimer's disease caregivers to tap into the
 expertise and resources of Mayo Clinic's Alzheimer's experts.  "Caregiver's
 Corner" is updated monthly to address a wide array of changing caregiver
 issues.
     "'Caregiver's Corner' is provided as part of Mayo Clinic's commitment to
 serve as a reliable and objective source of health information for the
 public," said Dr. Brooks Edwards, medical editor, MayoClinic.com. "The monthly
 articles are specifically designed to address the many challenges that
 caregivers of Alzheimer's patients face on a daily basis."
     The professional component of the site is designed to meet the varied
 needs of healthcare professionals by providing timely, practical information
 directly relevant to the treatment of Alzheimer's disease in clinical
 practice, as well as important issues related to caregiving. It includes
 information about the pathophysiology of Alzheimer's disease, diagnosis,
 caregiver issues, and provides a calendar/overview of upcoming medical
 meetings offering symposia related to the treatment of the disease.
     Alzheimer's disease is a neurodegenerative disease involving deterioration
 of the brain.  Memory loss, behavioral problems and the inability to perform
 daily activities are hallmarks of this fatal disease.  Alzheimer's disease,
 the fourth leading cause of death behind cardiovascular disease, cancer and
 stroke, affects up to four million adults in the United States, and ten
 million worldwide.  It has an annual U.S. price tag of approximately $100
 billion in direct (healthcare and related) and indirect (income) costs.
 
     Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation
 is an affiliate of the Novartis Group (NYSE:   NVS), a world leader in
 healthcare with core businesses in pharmaceuticals, consumer health, generics,
 eye-care, and animal health. In 2000, the Group's ongoing businesses achieved
 sales of CHF 29.1 billion (USD 17.2 billion) and invested approximately CHF
 4.0 billion (USD 2.4 billion) in R&D. Headquartered in Basel, Switzerland,
 Novartis employs about 67,600 people and operates in over 140 countries around
 the world. For further information please consult http://www.novartis.com.
 
     Contact:
     Gina Moran
     Novartis Pharmaceuticals Corporation
     PH: (973) 781-5567
     FX: (973) 781-7828
 
     Rod Smith
     Feinstein Kean Healthcare
     PH: (617) 761-6723
     FX: (617) 577-8985
     Rsmith@fkhealth.com
 
 SOURCE  Novartis Pharmaceuticals Corporation